Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Gottlieb Renews Call For New Opioid Review Paradigm As Democrats Prepare For House Control

Nov 09 2018

• By Michael Cipriano

Medical advice and medication guidance and prescription drugs health consultation as a giant pill shaped as a lighthouse beacon with 3D illustration elements.

Related Content

Trevena's IV Opioid Not Quite 'Ready for Primetime,' US FDA Panel Concludes

Oct 12 2018

Dsuvia's Thumbs Up From US FDA Advisory Panel Is First Positive Vote For An Opioid In 2018

Oct 15 2018

Public Citizen: US FDA Deliberately Excluded Risk Committee From Dsuvia Panel To Get Positive Vote

Oct 19 2018

AcelRx's Sublingual Opioid Dsuvia Brings Unique Risk To Advisory Panel: Dropped Tablets

Oct 11 2018

Opioid Policy At US FDA: Over-Promising Or Overreacting?

Oct 25 2018

Opioid REMS Increases Nearly Six-Fold As US FDA Adds Immediate-Release Products

Sep 19 2018

US FDA May Largely Avoid House Democrats' Investigation Agenda

Nov 08 2018

Dsuvia Approval May Be Followed By New Opioid Review Paradigm At FDA

Nov 02 2018

Related Companies

Trevena Inc.

Talphera, Inc.

Additional Topics

United States Elections Drug Safety Regulation Legislation Neurology BioPharmaceutical

More from Elections

More from Legislation

Twitter feed RSS feed RSS feed

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window

Copyright © 2025 Pharma Intelligence UK Limited (Citeline), a Norstella company Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered.